| Literature DB >> 24632009 |
Ben Grayson1, Lisa Adamson2, Michael Harte2, Marianne Leger2, Samuel Marsh2, Chloe Piercy2, Joanna C Neill3.
Abstract
Recognition memory, impaired in neuropsychiatric conditions and currently untreated, may be assessed by the novel object recognition (NOR) task with robust impairments induced by sub-chronic treatment with the N-methyl-d-aspartate receptor antagonist phencyclidine (PCP). The aim of the present study was to investigate how sub-chronic PCP produces its effects in this task. Forty adult female rats received vehicle or PCP (2mg/kg i.p. twice daily for 7 days followed by 7 days washout). Rats completed a 3-min acquisition trial followed by differential inter-trial-interval (ITI) conditions (1 min in the home cage, 10s in the home cage, 1 min in the NOR test box in the presence of an unfamiliar object or 1 min in the NOR test box completely undisturbed) followed by a 3-min retention trial. Control rats spent significantly more time exploring the novel compared with the familiar object in retention. This effect was abolished in the sub-chronic PCP treated animals following all ITI conditions except in rats left completely undisturbed in the NOR test box for a 1 min ITI. The combined influence of sub-chronic PCP treatment and the effect of distraction provides further support for the validity of the NOR test in mimicking cognitive deficits of relevance to schizophrenia.Entities:
Keywords: Animal models; Cognition; Object recognition memory; Phencyclidine; Rat; Schizophrenia
Mesh:
Substances:
Year: 2014 PMID: 24632009 DOI: 10.1016/j.bbr.2014.03.011
Source DB: PubMed Journal: Behav Brain Res ISSN: 0166-4328 Impact factor: 3.332